Literature DB >> 17489580

Antibacterial nicotinamide adenine dinucleotide synthetase inhibitors: amide- and ether-linked tethered dimers with alpha-amino acid end groups.

Sadanandan E Velu1, Liyuan Mou, Chi-Hao Luan, Zhengrong W Yang, Lawrence J DeLucas, Christie G Brouillette, Wayne J Brouillette.   

Abstract

Tethered dimers incorporating natural alpha-amino acid end groups were synthesized, including examples in which the previously reported esterase-sensitive ester linker was replaced with more stable amide or ether linkers. These compounds remained effective both as inhibitors of NAD synthetase and as potent antibacterial agents for Gram-positive strains. Studies on nonspecific effects, including detergent properties and promiscuous inhibition, suggested little contribution to observed activities.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17489580     DOI: 10.1021/jm061349l

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  10 in total

1.  Genomics-driven reconstruction of acinetobacter NAD metabolism: insights for antibacterial target selection.

Authors:  Leonardo Sorci; Ian Blaby; Jessica De Ingeniis; Svetlana Gerdes; Nadia Raffaelli; Valérie de Crécy Lagard; Andrei Osterman
Journal:  J Biol Chem       Date:  2010-10-06       Impact factor: 5.157

2.  Design, synthesis, and evaluation of substituted nicotinamide adenine dinucleotide (NAD+) synthetase inhibitors as potential antitubercular agents.

Authors:  Xu Wang; Yong-Mo Ahn; Adam G Lentscher; Julia S Lister; Robert C Brothers; Malea M Kneen; Barbara Gerratana; Helena I Boshoff; Cynthia S Dowd
Journal:  Bioorg Med Chem Lett       Date:  2017-08-08       Impact factor: 2.823

3.  Cloning, expression, purification, crystallization and preliminary X-ray diffraction studies of NAD synthetase from methicillin-resistant Staphylococcus aureus.

Authors:  Gajanan Kashinathrao Arbade; Sandeep Kumar Srivastava
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-05-22       Impact factor: 1.056

4.  High-resolution crystal structures of Streptococcus pneumoniae nicotinamidase with trapped intermediates provide insights into the catalytic mechanism and inhibition by aldehydes .

Authors:  Jarrod B French; Yana Cen; Anthony A Sauve; Steven E Ealick
Journal:  Biochemistry       Date:  2010-09-20       Impact factor: 3.162

5.  NAD+ auxotrophy is bacteriocidal for the tubercle bacilli.

Authors:  Catherine Vilchèze; Brian Weinrick; Ka-Wing Wong; Bing Chen; William R Jacobs
Journal:  Mol Microbiol       Date:  2010-02-28       Impact factor: 3.501

6.  Targeting NAD biosynthesis in bacterial pathogens: Structure-based development of inhibitors of nicotinate mononucleotide adenylyltransferase NadD.

Authors:  Leonardo Sorci; Yongping Pan; Yvonne Eyobo; Irina Rodionova; Nian Huang; Oleg Kurnasov; Shijun Zhong; Alexander D MacKerell; Hong Zhang; Andrei L Osterman
Journal:  Chem Biol       Date:  2009-08-28

7.  Quinolinate salvage and insights for targeting NAD biosynthesis in group A streptococci.

Authors:  Leonardo Sorci; Ian K Blaby; Irina A Rodionova; Jessica De Ingeniis; Sergey Tkachenko; Valérie de Crécy-Lagard; Andrei L Osterman
Journal:  J Bacteriol       Date:  2012-11-30       Impact factor: 3.490

8.  SAR studies for a new class of antibacterial NAD biosynthesis inhibitors.

Authors:  Whitney Beysselance Moro; Zhengrong Yang; Tasha A Kane; Qingxian Zhou; Steve Harville; Christie G Brouillette; Wayne J Brouillette
Journal:  J Comb Chem       Date:  2009 Jul-Aug

9.  Virtual screening to identify lead inhibitors for bacterial NAD synthetase (NADs).

Authors:  Whitney Beysselance Moro; Zhengrong Yang; Tasha A Kane; Christie G Brouillette; Wayne J Brouillette
Journal:  Bioorg Med Chem Lett       Date:  2009-02-12       Impact factor: 2.823

10.  Glutamine versus ammonia utilization in the NAD synthetase family.

Authors:  Jessica De Ingeniis; Marat D Kazanov; Konstantin Shatalin; Mikhail S Gelfand; Andrei L Osterman; Leonardo Sorci
Journal:  PLoS One       Date:  2012-06-15       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.